Smith Graham & Co Investment Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-22,100
| Closed | -$2.73M | – | 140 |
|
|
2021
Q4 | $2.73M | Sell |
22,100
-325
| -1% | -$42.5K | 0.27% | 138 |
|
|
2021
Q3 | $3.19M | Sell |
22,425
-2,473
| -10% | -$364K | 0.32% | 131 |
|
|
2021
Q2 | $3.89M | Sell |
24,898
-4,013
| -14% | -$650K | 0.34% | 130 |
|
|
2021
Q1 | $4.49M | Sell |
28,911
-3,800
| -12% | -$589K | 0.36% | 124 |
|
|
2020
Q4 | $4.89M | Sell |
32,711
-3,055
| -9% | -$431K | 0.45% | 101 |
|
|
2020
Q3 | $4.73M | Sell |
35,766
-1,516
| -4% | -$198K | 0.54% | 87 |
|
|
2020
Q2 | $4.32M | Buy |
37,282
+138
| +0.4% | +$15.9K | 0.52% | 91 |
|
|
2020
Q1 | $3.65M | Buy |
37,144
+260
| +0.7% | +$34.1K | 0.57% | 82 |
|
|
2019
Q4 | $5.36M | Sell |
36,884
-969
| -3% | -$134K | 0.52% | 111 |
|
|
2019
Q3 | $5.04M | Buy |
37,853
+83
| +0.2% | +$10.7K | 0.54% | 110 |
|
|
2019
Q2 | $4.32M | Sell |
37,770
-1,628
| -4% | -$191K | 0.47% | 123 |
|
|
2019
Q1 | $4.88M | Buy |
39,398
+382
| +1% | +$43.4K | 0.54% | 114 |
|
|
2018
Q4 | $3.93M | Sell |
39,016
-248
| -0.6% | -$27.9K | 0.48% | 125 |
|
|
2018
Q3 | $5.01M | Sell |
39,264
-1,596
| -4% | -$190K | 0.47% | 120 |
|
|
2018
Q2 | $4.42M | Sell |
40,860
-834
| -2% | -$90.8K | 0.42% | 128 |
|
|
2018
Q1 | $4.41M | Sell |
41,694
-454
| -1% | -$52.7K | 0.43% | 124 |
|
|
2017
Q4 | $4.94M | Buy |
42,148
+7,488
| +22% | +$847K | 0.46% | 122 |
|
|
2017
Q3 | $3.94M | Sell |
34,660
-247
| -0.7% | -$28.5K | 0.41% | 123 |
|
|
2017
Q2 | $4.35M | Sell |
34,907
-340
| -1% | -$40.3K | 0.47% | 107 |
|
|
2017
Q1 | $4.18M | Sell |
35,247
-226
| -0.6% | -$25.6K | 0.45% | 110 |
|
|
2016
Q4 | $3.55M | Buy |
35,473
+5,119
| +17% | +$549K | 0.38% | 120 |
|
|
2016
Q3 | $3.83M | Sell |
30,354
-453
| -1% | -$56K | 0.49% | 111 |
|
|
2016
Q2 | $3.6M | Sell |
30,807
-196
| -0.6% | -$22.2K | 0.5% | 112 |
|
|
2016
Q1 | $3.21M | Buy |
31,003
+3,131
| +11% | +$303K | 0.42% | 127 |
|
|
2015
Q4 | $2.78M | Buy |
27,872
+907
| +3% | +$88.7K | 0.39% | 125 |
|
|
2015
Q3 | $2.46M | Buy |
26,965
+587
| +2% | +$58.8K | 0.36% | 128 |
|
|
2015
Q2 | $2.8M | Sell |
26,378
-217
| -0.8% | -$24K | 0.38% | 119 |
|
|
2015
Q1 | $3.03M | Sell |
26,595
-195
| -0.7% | -$22.2K | 0.41% | 111 |
|
|
2014
Q4 | $2.95M | Buy |
26,790
+412
| +2% | +$43.4K | 0.42% | 111 |
|
|
2014
Q3 | $2.58M | Buy |
26,378
+1,576
| +6% | +$155K | 0.38% | 119 |
|
|
2014
Q2 | $2.5M | Sell |
24,802
-268
| -1% | -$26.1K | 0.35% | 119 |
|
|
2014
Q1 | $2.3M | Sell |
25,070
-392
| -2% | -$36.1K | 0.33% | 118 |
|
|
2013
Q4 | $2.3M | Sell |
25,462
-9,342
| -27% | -$808K | 0.33% | 112 |
|
|
2013
Q3 | $2.78M | Sell |
34,804
-412
| -1% | -$32.4K | 0.4% | 113 |
|
|
2013
Q2 | $2.56M | Buy |
+35,216
| New | +$2.63M | 0.4% | 113 |
|
Other funds holding ZBH
Smith Graham & Co Investment Advisors's ZBH Position: Q1 2022 in Review
Smith Graham & Co Investment Advisors sold out of Zimmer Biomet (ZBH) in Q1 2022, closing a stake of 22,100 shares — an estimated $2.73M sold.
Smith Graham & Co Investment Advisors first reported a position in ZBH in Q2 2013 and held it in 35 quarters. The position peaked at $5.36M in Q4 2019. 977 funds tracked by Wall St. Rank hold ZBH as of Q1 2022.
- Smith Graham & Co Investment Advisors reported no remaining Zimmer Biomet position as of Q1 2022 after selling out during the quarter.
- Smith Graham & Co Investment Advisors sold 22,100 Zimmer Biomet shares in Q1 2022, an estimated $2.73M.
- Smith Graham & Co Investment Advisors first reported a position in Zimmer Biomet in Q2 2013 and held it in 35 quarters.
- Smith Graham & Co Investment Advisors's Zimmer Biomet position peaked at $5.36M in Q4 2019.
- 977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2022.
Based on Smith Graham & Co Investment Advisors's 13F filing for Q1 2022, filed 6 May 2022.